Atlas Trials

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

Clinical trial NCT00407251 · COMPLETED

Trial details

NCT number
NCT00407251
Sponsor
British Columbia Cancer Agency
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone Refractory Prostate Cancer
Start date
2007-02-01
Primary completion
2010-06-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.